Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis

Background: Currently, there is no topical treatment available for any form of cutaneous leishmaniasis (CL) in most of the endemic areas. The aim of the current study was to develop a topical nano-liposomal Amphotericin B (AmB) for the treatment of CL. Methodology/principal findings: Liposomes conta...

Full description

Bibliographic Details
Main Authors: Mahmoud Reza Jaafari, Mahdi Hatamipour, Seyedeh Hoda Alavizadeh, Azam Abbasi, Zahra Saberi, Sima Rafati, Yasaman Taslimi, Akram Miramin Mohammadi, Ali Khamesipour
Format: Article
Language:English
Published: Elsevier 2019-12-01
Series:International Journal for Parasitology: Drugs and Drug Resistance
Online Access:http://www.sciencedirect.com/science/article/pii/S2211320719300545

Internet

http://www.sciencedirect.com/science/article/pii/S2211320719300545

Similar Items